In this cohort study, the number of the deceased/total NPC patients in the “high” MTSS1 group was 2 out of 44 (<5%), while in “low” MTSS1 group this number increased dramatically to 11 out of 44 (25%). This evidence concerns the gene MTSS1 and nasopharyngeal carcinoma.